Enfermedades Infecciosas

Valerio, M; Machado, M; Cedeno, S; Rodriguez, ML; Anaya, F; Vena, A; Guinea, J; Escribano, P; Bouza, E; Munoz, P.

Donor-derived invasive aspergillosis after kidney transplant

Medical Mycology Case Reports. 2018; 22: 24-26 Nº de citas: 4 [doi:10.1016/j.mmcr.2018.07.004]

Acosta, F; Perez-Lago, L; Serrano, MJR; Marin, M; Kohl, TA; Lozano, N; Niemann, S; Valerio, M; Olmedo, M; Perez-Granda, MJ; Perez, MR; Bouza, E; Munoz, P; de Viedma, DG.

Fast update of undetected Mycobacterium chimaera infections to reveal unsuspected cases

JOURNAL OF HOSPITAL INFECTION. 2018; 100(4): 451-455 Nº de citas: 6 [doi:10.1016/j.jhin.2018.08.018]

Perez-Granda, MJ; Alonso, B; Rodriguez-Huerta, A; Rodriguez, C; Guembe, M.

In vitro assessment of the anti-biofilm activity of ethanol alone and in combination with enoxaparin 60 IU

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36(10): 627-632 Nº de citas: 1 [doi:10.1016/j.eimc.2017.11.007]

Dandachi, D; Dib, RW; Fernandez-Cruz, A; Jiang, Y; Chaftari, AM; Hachem, R; Raad, I.

Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes

ANNALS OF MEDICINE. 2018; 50(8): 713-720 Nº de citas: 16 [doi:10.1080/07853890.2018.1518581]

Vehreschild, MJGT; Taori, S; Goldenberg, SD; Thalhammer, F; Bouza, E; van Oene, J; Wetherill, G; Georgopali, A.

Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2018; 37(11): 2097-2106 Nº de citas: 14 [doi:10.1007/s10096-018-3344-1]

Kumar, D; Ferreira, VH; Blumberg, E; Silveira, F; Cordero, E; Perez-Romero, P; Aydillo, T; Danziger-Isakov, L; Limaye, AP; Carratala, J; Munoz, P; Montejo, M; Lopez-Medrano, F; Farinas, MC; Gavalda, J; Moreno, A; Levi, M; Fortun, J; Torre-Cisneros, J; Englund, JA; Natori, Y; Husain, S; Reid, G; Sharma, TS; Humar, A.

A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients

CLINICAL INFECTIOUS DISEASES. 2018; 67(9): 1322-1329 Nº de citas: 136 [doi:10.1093/cid/ciy294]

Arendrup, MC; Meletiadis, J; Zaragoza, O; Jorgensen, KM; Marcos-Zambrano, LJ; Kanioura, L; Cuenca-Estrella, M; Mouton, JW; Guinea, J.

Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method

CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(11): 1200-1204 Nº de citas: 37 [doi:10.1016/j.cmi.2018.02.021]

ALONSO FERNANDEZ, BEATRIZ; PEREZ GRANDA, MARIA JESUS; RODRÍGUEZ HUERTA, ANA MARÍA; RODRÍGUEZ GONZÁLEZ, CARMEN GUADALUPE; BOUZA SANTIAGO, EMILIO.

The optimal ethanol lock therapy regimen for treatment of biofilm-associated catheter infections: an in-vitro study

JOURNAL OF HOSPITAL INFECTION. 2018; 100(3): 187-195 Nº de citas: 11 [doi:10.1016/j.jhin.2018.04.007]

Reigadas, E; Olmedo, M; Valerio, M; Vazquez-Cuesta, S; Alcala, L; Marin, M; Munoz, P; Bouza, E.

Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2018; 31(5): 411-418 Nº de citas: 7

De Viedma, DG; Perez-Lago, L.

The Evolution of Genotyping Strategies To Detect, Analyze, and Control Transmission of Tuberculosis

Microbiology spectrum. 2018; 6(5): Nº de citas: 11 [doi:10.1128/microbiolspec.MTBP-0002-2016]

Munoz, P; Valerio, M; Vasquez, V; Velasquez-Rodriguez, J; Sousa, I; Zatarain, E; Barrio, JM; Ruiz, M; Cuerpo, G; Rodriguez-Abella, H; Hortal, J; Bouza, E; Grp Apoyo Manejo Asistencias Ventr.

Infections in patients after Berlin Heart((R)) EXCOR assist device implantation

TRANSPLANT INFECTIOUS DISEASE. 2018; 20(5): Nº de citas: 8 [doi:10.1111/tid.12936]

Fernandez-Cruz, A; Magira, E; Heo, ST; Evans, S; Tarrand, J; Kontoyiannis, DP.

Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes

JOURNAL OF CLINICAL MICROBIOLOGY. 2018; 56(10): Nº de citas: 8 [doi:10.1128/JCM.00962-18]

Valerio, M; Vena, A; Rodriguez-Gonzalez, CG; de Vega, EC; Mateos, M; Sanjurjo, M; Bouza, E; Munoz, P.

Repeated antifungal use audits are essential for selecting the targets for intervention in antifungal stewardship

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2018; 37(10): 1993-2000 Nº de citas: 14 [doi:10.1007/s10096-018-3335-2]

Bordallo-Cardona, MA; Escribano, P; Marcos-Zambrano, LJ; Diaz-Garcia, J; G Gomez de la Pedrosa, Elia; Canton, R; Bouza, E; Guinea, J.

Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata

MEDICAL MYCOLOGY. 2018; 56(7): 903-906 Nº de citas: 12 [doi:10.1093/mmy/myx124]

Bouza, E; Munoz, P; Burillo, A.

Role of the Clinical Microbiology Laboratory in Antimicrobial Stewardship

MEDICAL CLINICS OF NORTH AMERICA. 2018; 102(5): 883-898 Nº de citas: 11 [doi:10.1016/j.mcna.2018.05.003]

Stargardt, T; Eckmann, C; Bouza, E; Rossolini, GM; Grossi, PA.

Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2018; 37(9): 1611-1618 Nº de citas: 5 [doi:10.1007/s10096-018-3264-0]

Muñoz P; Agnelli, C; Guinea, J; Vena, A; Alvarez-Uria, A; Marcos-Zambrano, LJ; Escribano, P; Valerio, M; Bouza, E.

Is biofilm production a prognostic marker in adults with candidaemia?

CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(9): 1010-1015 Nº de citas: 18 [doi:10.1016/j.cmi.2018.01.022]

Martin-Diaz, A; Rubio, JM; Herrero-Martinez, JM; Lizasoain, M; Ruiz-Giardin, JM; Jaqueti, J; Cuadros, J; Rojo-Marcos, G; Martin-Rabadan, P; Calderon, M; Campelo, C; Velasco, M; Perez-Ayala, A.

Study of the diagnostic accuracy of microbiological techniques in the diagnosis of malaria in the immigrant population in Madrid

MALARIA JOURNAL. 2018; 17: 314-314 Nº de citas: 6 [doi:10.1186/s12936-018-2459-2]